The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 20.11
Cancer of the Oral Cavity and Pharynx by Subsite (Invasive)
SEERa Relative Survival (Percent) by Cancer Site, 2005-2011
| Site | Number of Cases | Case Distribution(%) | 1-Year Survival | 2-Year Survival | 3-Year Survival | 4-Year Survival | 5-Year Survival |
|---|---|---|---|---|---|---|---|
| Oral Cavity & Pharynx | 52240 | 100 | 83.7 | 74.2 | 69.2 | 65.7 | 63.2 |
| Lip | 3158 | 6 | 98.2 | 94.6 | 92.6 | 91.1 | 90.2 |
| Tongue | 15237 | 29 | 84.0 | 73.6 | 68.5 | 65.4 | 63.4 |
| Gum & Other Mouth | 6529 | 12 | 81.2 | 71.3 | 65.9 | 62.4 | 59.6 |
| Floor of Mouth | 2650 | 5 | 79.7 | 67.5 | 60.3 | 55.3 | 50.5 |
| Oropharynx & Tonsil | 11531 | 22 | 85.6 | 77.1 | 72.4 | 69.1 | 66.8 |
| Hypopharynx | 2905 | 6 | 65.4 | 48.6 | 41.5 | 36.7 | 32.2 |
| Salivary Gland | 5896 | 11 | 88.7 | 81.6 | 77.5 | 74.1 | 72.7 |
| Nasopharynx | 3464 | 7 | 83.4 | 74.5 | 68.3 | 63.8 | 59.6 |
| Other Oral Cavity & Pharynx | 870 | 2 | 61.5 | 51.7 | 47.4 | 44.6 | 39.3 |
| Site | All Races, Both Sexes | All Stages | |||||||
|---|---|---|---|---|---|---|---|---|---|
| All Stages | Localized | Regional | Distant | Unstaged | White Male | White Female | Black Male | Black Female | |
| Oral Cavity & Pharynx | 63.2 | 83.0 | 61.5 | 37.7 | 47.9 | 64.4 | 65.9 | 40.5 | 53.3 |
| Lip | 90.2 | 94.3 | 51.9b | 38.8b | 78.0 | 90.8 | 88.2 | - | - |
| Tongue | 63.4 | 78.4 | 63.4 | 36.3 | 52.1 | 65.7 | 64.0 | 36.8 | 41.0 |
| Gum & Other Mouthd | 59.6 | - | - | - | - | 56.9 | 62.9 | 46.5 | 60.6 |
| Floor of Mouth | 50.5 | 75.4 | 36.1 | 16.9 | 41.7b | 49.8 | 56.7 | 32.6 | 40.8b |
| Oropharynx & Tonsild | 66.8 | - | - | - | - | 70.4 | 63.3 | 45.2 | 40.8 |
| Hypopharynxd | 32.2 | - | - | - | - | 35.3 | 34.5 | 15.7 | 27.3b |
| Salivary Gland | 72.7 | 93.2 | 66.4 | 37.9 | 53.9 | 64.0 | 82.5 | 66.4 | 81.4 |
| Nasopharynxd | 59.6 | - | - | - | - | 56.3 | 57.0 | 50.5 | 57.6b |
| Other Oral Cavity & Pharynxd | 39.3 | - | - | - | - | 46.1 | 35.1 | 25.4b | 15.3b |
Footnotes:
a SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Based on follow-up of patients into 2012.
b The standard error is between 5 and 10 percentage points.
c The standard error is greater than 10 percentage points.
d Survival by stage was not calculated for this site due to inconsistent coding of stage over time.
- Statistic could not be calculated due to fewer than 25 cases during the time period.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.